ct-95

·Code: LNK-101

ct-95: developed by 1 company · 1 FDA decision. Updated within the last hour.

Development Pipeline (1)

CompanyPhase
Context Therapeutics Inc. (CNTX)Phase 1

FDA Decisions

FDA_MeetingThe U.S. FDA cleared the investigational new drug (IND) application for CT-95.(CNTX)

Frequently asked questions

Who is developing ct-95?

ct-95 is being developed by Context Therapeutics Inc..

What is ct-95's latest FDA decision?

The most recent tracked FDA decision for ct-95 is FDA_Meeting for The U.S. FDA cleared the investigational new drug (IND) application for CT-95..

Get deeper analysis on ct-95

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    ct-95 — Drug Pipeline, Trials & FDA Status | BioSniper